Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID)
出版年份 2015 全文链接
标题
Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID)
作者
关键词
Multiple sclerosis, Neuromyelitis optica, Treatment, Rituximab
出版物
Journal of Neuroimmune Pharmacology
Volume 11, Issue 1, Pages 1-8
出版商
Springer Nature
发表日期
2015-11-20
DOI
10.1007/s11481-015-9646-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Registers of multiple sclerosis in Denmark
- (2015) N. Koch-Henriksen et al. ACTA NEUROLOGICA SCANDINAVICA
- The off-label use of targeted therapies in sarcomas: the OUTC’S program
- (2014) Lauriane Eberst et al. BMC CANCER
- Neuromyelitis optica: clinical features, immunopathogenesis and treatment
- (2014) S. Jarius et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Rituximab Use in Pediatric Central Demyelinating Disease
- (2014) Shannon J. Beres et al. PEDIATRIC NEUROLOGY
- B cells in MS and NMO: pathogenesis and therapy
- (2014) Markus Krumbholz et al. Seminars in Immunopathology
- Therapeutic Plasma Exchange in Glucocorticosteroid-Unresponsive Patients With Clinically Isolated Syndrome
- (2014) Johannes Ehler et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Requirement for safety monitoring for approved multiple sclerosis therapies: an overview
- (2013) P. S. Rommer et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Management of Secondary Progressive Multiple Sclerosis: Prophylactic Treatment—Past, Present, and Future Aspects
- (2013) Paulus S. Rommer et al. Current Treatment Options in Neurology
- Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
- (2013) Corinna Trebst et al. JOURNAL OF NEUROLOGY
- Immunopathogenic mechanisms of systemic autoimmune disease
- (2013) Marie Wahren-Herlenius et al. LANCET
- A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder
- (2013) Su-Hyun Kim et al. JAMA Neurology
- Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases
- (2012) Paulus S. Rommer et al. CURRENT PHARMACEUTICAL DESIGN
- Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
- (2012) Sven Jarius et al. Journal of Neuroinflammation
- Immune-mediated CNS diseases: A review on nosological classification and clinical features
- (2011) Uwe K. Zettl et al. AUTOIMMUNITY REVIEWS
- Rituximab for Secondary Progressive Multiple Sclerosis
- (2011) Paulus S. Rommer et al. CNS DRUGS
- Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
- (2011) H. L. Pellkofer et al. NEUROLOGY
- Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
- (2011) Hans-Peter Tony et al. ARTHRITIS RESEARCH & THERAPY
- MS and the B cell controversy
- (2010) Anne H. Cross et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The Potential Role of B Cell-Targeted Therapies in Multiple Sclerosis
- (2010) Aaron Boster et al. DRUGS
- Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: A 52-week phase II trial
- (2010) R. T. Naismith et al. NEUROLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Treatment of Neuromyelitis Optica With Rituximab
- (2008) ARCHIVES OF NEUROLOGY
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now